Construction method and application of specific hypothalamic POMC neuron SIRT1 overexpression mouse model

The SIRT1 overexpression model of specific hypothalamic POMC neurons was constructed in mice through CRISPR/Cas9 technology, which solved the problems of high gene editing efficiency and cost in the existing technology, realized effective means of SIRT1 function research, and studied obesity Show actual contributions.

CN119061070AInactive Publication Date: 2024-12-03NANJING BRAIN HOSPITAL
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411394193.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-08
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Although existing gene editing technologies such as ZFNs, TALEN and CRISPR/Cas9 have improved gene editing efficiency, they still have complex protein design, expensive cost and high difficulty in the application process, which limits their wide application, especially A valid overexpression mouse model was lacking in the study of silencing protein 1 (SIRT1) function.

Method used

The CAG-LSL-mSIRT1-3-3xFlag-WPRE-PolyA gene fragment was inserted into the H11 site of mice by microinjecting the CRISPR/Cas9 system and homologous recombinant vector to construct specific hypothalamic POMCs. A mouse model of neuronal SIRT1 overexpression achieves stable inheritance and validates gene editing.

Benefits of technology

A mouse model of SIRT1 overexpression of specific hypothalamic POMC neurons was successfully constructed to study the functions of SIRT1 in cell aging, tumorigenesis and development, DNA damage repair, and nervous system development, and showed glucose in diet-induced obesity Impaired tolerance has high scientific and socio-economic value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061070A_ABST
    Figure CN119061070A_ABST
Patent Text Reader

Abstract

The invention provides a construction method of a specific hypothalamic POMC neuron SIRT1 overexpression mouse model and application of the specific hypothalamic POMC neuron SIRT1 overexpression mouse model. The construction method comprises the following steps: inserting a CAG-LSL-mSIRT1-3-3xFlag-WPRE-PolyA gene segment into an H11 site of a mouse at a fixed point by utilizing a CRISPR / Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats / CRISPR associated 9) technology; the sequence behind the H11 site of the recombined mouse is as shown in SEQ ID NO. 1. According to the scheme, sgRNA is reasonably designed and modified, and high specificity and low off-target rate of the constructed homologous recombinant vector are ensured. A target gene needing to be edited and a carrier of the target gene are introduced into a mouse body in a microinjection mode, so that stable inheritance of editing of the target gene is realized, and finally a gene editing animal with stable inheritance is obtained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the biological field and relates to a method for constructing a specific hypothalamic POMC neuron SIRT1 overexpression mouse model and an application thereof. Background Art

[0002] ZFNs (zinc finger nuclease) technology is the first generation of genome editing technology, which is inefficient and time-consuming. The emergence of the second generation of gene editing technology TALEN has greatly improved the efficiency of gene editing. TALEN is a synthetic protein that can produce sticky overhang DSB after cutting the target sequence. TALEN has greatly accelerated the development of gene editing technology, but in the application process, its complex protein design, high cost and high difficulty still limit the widespread application of gene editing technology. The third generation of gene editing technology CRISPR / Cas9 system does not require the design of complex DNA binding proteins and the fusion process of DNA binding proteins and Fok I nuclease. sgRNA can be quickly designed and preliminarily screened through software. At the same time, by changing a small sequence in sgRNA, the CRISPR / Cas9 system can quickly edit other gene sites.

[0003] Sirtuin 1 (SIRT1) is a mammalian protein that is highly homologous to yeast silencing information regulator 2 (SIR2). It is a class III histone deacetylase (HDAC) that depends on nicotinamide adenine dinucleotide (NAD+). It plays an important role in cell differentiation, aging, apoptosis, DNA damage repair, energy and endocrine metabolism regulation. It also plays an important biological function in gene silencing, epigenetic modification, transcriptional regulation and signal transduction regulation. However, there are few studies on sirtuin 1. Therefore, it is urgent to provide a SIRT1 overexpression mouse, intervene in the activity of SIRT1 in mice through modern genetic engineering technology, and study the various functions of SIRT1 gene, such as cell aging, tumor occurrence and development, DNA damage repair, and development of the nervous system. Summary of the invention

[0004] In view of the deficiencies of the prior art, the present invention provides a method for constructing a mouse model of SIRT1 overexpression in specific hypothalamic POMC neurons and its application. The present invention rationally designs and modifies sgRNA to ensure the high specificity and low off-target rate of the constructed homologous recombination vector. The target gene to be edited and its vector are introduced into the mouse body by microinjection to achieve stable inheritance of the editing of the target gene, and finally obtain gene-edited animals with stable inheritance.

[0005] The technical solution provided by the present invention is as follows:

[0006] The method for constructing a specific hypothalamic POMC neuron SIRT1 overexpression mouse model comprises the following steps: using CRISPR / Cas9 technology to site-specifically insert the CAG-LSL-mSIRT1-3-3xFlag-WPRE-PolyA gene fragment into the H11 site of the mouse; the sequence after the H11 site of the recombinant mouse is shown in SEQ ID NO.1.

[0007] Furthermore, the CRISPR / Cas9 system and homologous recombination vector were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 mice; the F0 positive mice verified correct by PCR gene identification were mated with C57BL / 6JGpt mice to obtain a stably inherited F1 positive mouse model; the F1 mice were mated with POMC-Cre mice to obtain F2 mice and their genes were identified.

[0008] Furthermore, a homologous recombination vector carrying the target site homologous region and the target fragment was constructed; the transcribed sgRNA and Cas9 system and the purified homologous recombination vector sample were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 generation mice.

[0009] Furthermore, the identification primers of the homologous recombination vector are as follows:

[0010] 1213513-SeqF1:tccccatcaagctgataaca;

[0011] 1213513-SeqR2:GCTCAGGTGGAGGAATTGTT;

[0012] 1213513-SeqF5:ccaagcaacaaacaacaatg;

[0013] H11-3arm-TR: CTCAGGACCTCTGAAAGACC.

[0014] Furthermore, the sequence of sgRNA was 5′-CTGAGCCAACAGTGGTAGTA-3′.

[0015] Further, the identification primers for F0 generation mice are as follows:

[0016] H11-tF2:ATGCCCACCAAAGTCATCAGTGTAG;

[0017] H11-CAG-5tR2: AGGCGGGCCATTTACCGTAAGTTA;

[0018] WPRE-tF1: TCAATCCAGCGGACCTTCCTT;

[0019] H11-tR1: GACCCACTATTCTGCACCACTCATTAG;

[0020] H11-wt-tF1a:AGTCTTTCCCTTGCCTCTGCT;

[0021] H11-wt-tR1a: GGGTCTTCCACCTTTCTTCAG;

[0022] Further, the identification primers for F1 generation mice are as follows:

[0023] H11-tF2:ATGCCCACCAAAGTCATCAGTGTAG;

[0024] H11-CAG-5tR2: AGGCGGGCCATTTACCGTAAGTTA;

[0025] WPRE-tF1: TCAATCCAGCGGACCTTCCTT;

[0026] H11-tR2:TCACAGAAACCATATGGCGCTCC;

[0027] H11-wt-tF1a:AGTCTTTCCCTTGCCTCTGCT;

[0028] H11-wt-tR1a: GGGTCTTCCACCTTTCTTCAG.

[0029] Further, the identification primers for F2 generation mice are as follows:

[0030] WPRE-tF1: TCAATCCAGCGGACCTTCCTT;

[0031] H11-tR3:ATATCCCCTTGTTCCCTTTCTGC;

[0032] H11-wt-tF1a:AGTCTTTCCCTTGCCTCTGCT;

[0033] H11-wt-tR1a: GGGTCTTCCACCTTTCTTCAG;

[0034] oIMR1084: GCGGTCTGGCAGTAAAAACTATC;

[0035] oIMR1085:GTGAAACAGCATTGCTGTCACTT.

[0036] The present invention also provides the use of the specific hypothalamic POMC neuron SIRT1 overexpression mouse model constructed by the above method in the preparation of drugs.

[0037] Furthermore, the drug is a drug for improving obesity.

[0038] Beneficial Effects

[0039] SIRT1 (Sirtuin 1) is a key protein that belongs to the nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase class and plays an important role in physiological processes such as cell differentiation, aging, apoptosis, and DNA damage repair.

[0040] At the same time, SIRT1 can act as an energy sensor and play an important role in controlling body metabolism. In peripheral tissues, a large number of studies have shown that SIRT1 can regulate the metabolic processes of organs such as the liver, pancreas, and skeletal muscle. In the central nervous system, the hypothalamus plays a key role in controlling food intake and energy expenditure through the close coordination of multiple neuronal circuits. SIRT1 is also expressed in the hypothalamus, and its expression increases after fasting. Acute inhibition of hypothalamic SIRT1 suppresses fasting-induced hyperphagia in rats.

[0041] Since SIRT1 is expressed in POMC neurons, this metabolic sensor protein in this metabolic sensor neuron may play a key role in coordinating the body's energy homeostasis. Therefore, the present invention uses CRISPR / Cas9 technology to insert the CAG-LSL-mSIRT1-3-3xFlag-WPRE-PolyA gene fragment into the H11 site of the mouse. The sequence of sgRNA is 5′-CTGAGCCAACAGTGGTAGTA-3′. The CRISPR / Cas9 system and the homologous recombination vector were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 generation mice. The F0 generation positive mice verified by PCR were mated with C57BL / 6JGpt mice to obtain a stable and hereditary F1 generation positive mouse model. The F1 generation mice were mated with B012339STOCKTg (Pomc1-cre) 16LowlJ mice to obtain F2 generation mice and genetic identification was performed on them. Based on the CRISPR Cas9 system, we generated hypothalamic POMC neuron-specific SIRT1 overexpression mice and studied the differences in body weight, intake, and blood glucose between these mice (hereinafter referred to as OE mice) and their littermates (hereinafter referred to as WT) after diet-induced obesity. After 7 weeks of feeding, OE mice were heavier than WT mice, but there was no statistically significant difference in the cumulative intake of the two mice. At the same time, OE mice showed impaired glucose tolerance.

[0042] In addition, the H11-CAG-LSL-mSirt1-3×Flag-WPRE-PolyA mice generated in this process, i.e., SIRT1 overexpressing mice, can be bred with various Cre tool mice to initiate SIRT1 gene overexpression, thereby generating SIRT1 overexpressing mice in different regions, which can be used to study other functions of the SIRT1 gene, such as cell senescence, tumor occurrence and development, DNA damage repair, and development of the nervous system.

[0043] In conclusion, intervening in the activity of SIRT1 in mice through modern genetic engineering technology has great scientific significance and socioeconomic benefits for studying diseases closely related to SIRT1 function. BRIEF DESCRIPTION OF THE DRAWINGS

[0044] Figure 1 This is a design strategy diagram of the method for constructing a specific hypothalamic POMC neuron SIRT1 overexpression mouse model of the present invention.

[0045] Figure 2 It is a map of homologous recombination vectors.

[0046] Figure 3 This is a diagram of the homologous recombination vector identification results.

[0047] Figure 4 This is the enzyme cutting identification diagram of the homologous recombination vector.

[0048] Figure 5 This is a diagram of the identification strategy for F0 and F1 generation mice. Wild type: ①②PCR reaction did not obtain the Target band; ③PCR reaction can obtain a single WT band; Heterozygous: ①②PCR reaction can obtain the Target band; ③PCR reaction can obtain a single WT band; Homozygous: ①②PCR reaction can obtain the Target band; ③PCR reaction did not obtain a single WT band.

[0049] Figure 6 This is the result of the identification of F0 generation mice. Note: The numbers are the mouse tail numbers, P is the positive control, WT is C57BL / 6JGpt, N is the blank control, M is the DNA Marker, ②-1 is Figure 5 ② in the.

[0050] Figure 7 This is the result of F1 generation mouse identification. Note: The numbers are the mouse tail numbers, WT is C57BL / 6JGpt, N is the blank control, and M is the DNA Marker.

[0051] Figure 8This is the result of the identification of F2 mice. Note: The numbers are the tail numbers of the mice, P is the positive control, B6 is C57BL / 6JGpt, and N is the negative control.

[0052] Fig. 9 The difference in body weight, intake, and blood glucose between hypothalamic POMC neuron-specific SIRT1 overexpressing mice and their littermate control mice after diet-induced obesity. Among them, a is the expression of SIRT1 protein in mouse hypothalamic tissue (n=5 or 7); b is body weight gain (n=8); c is cumulative intake (n=8); d. Glucose tolerance curve (n=6); *p<0.05, **p<0.01. DETAILED DESCRIPTION

[0053] The present invention is described in detail below with reference to the accompanying drawings and specific examples. Unless otherwise specified in the following examples, the raw materials used are all commercially available, and the methods used are all conventional operating methods known to those skilled in the art.

[0054] Example 1 Method for constructing a mouse model of conditional SIRT1 gene overexpression

[0055] S1. Construction of CAG-LSL-mSirt1-3×Flag-WPRE-PolyA mice

[0056] 1. Experimental methods

[0057] 1.1 Vector construction

[0058] According to the design plan, sgRNA was designed, constructed and transcribed in vitro, and a homologous recombination vector (Donor vector) was constructed. The correctness of the vector sequence was verified by sequencing.

[0059] SIRT1 gene overexpression mouse: the name is T059878H11-CAG-LSL-mSirt1-3×Flag-WPRE-PolyA, the background is C57BL / 6JGpt, and it is the mouse generated in this example.

[0060] Cre tool mouse: The name is B012339STOCK Tg (Pomc1-cre) 16Lowl / J, abbreviated as POMC-Cre mouse. The jax website shows that the background is FVB / N. The actual mice have been backcrossed to C57BL / 6JGpt background. The original source is The Jackson Laboratory.

[0061] Using CRISPR / Cas9 technology, the CAG-LSL-mSIRT1-3-3xFlag-WPRE-PolyA gene fragment was site-specifically inserted into the H11 site of the mouse. The sequence of sgRNA is: 5'-CTGAGCCAACAGTGGTAGTA-3'. The CRISPR / Cas9 system and donor vector were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 generation mice. The F0 generation positive mice verified by PCR were mated with C57BL / 6JGpt mice to obtain a stable and heritable F1 generation positive mouse model. The F1 generation mice were mated with B012339STOCKTg (Pomc1-cre)16LowlJ mice to obtain F2 generation mice and their genes were identified. The design strategy is shown in the figure below. Figure 1 shown.

[0062] Using the CRISPR Design tool of MIT (http: / / crispr.tefor.net / ), a pair of 20bp oligonucleotide chain sequences for the target DNA were designed according to the score to prepare sgRNA. At the same time, a homologous recombination vector carrying the homologous region of the target site and the target fragment was constructed. The transcribed sgRNA and Cas9 system and the purified homologous recombination vector samples were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 generation mice. Since the early cleavage rate of the fertilized egg is very fast, the obtained F0 generation mice are chimeras and may not have the ability of stable inheritance. Therefore, it is necessary to mate the F0 generation mice identified by PCR amplification with C57BL / 6J mice to obtain positive F1 generation mice. The positive F1 generation heterozygous mice can be stably inherited. The sgRNA sequence information is: 5'-CTGAGCCAACAGTGGTAGTA-3' (SEQID NO.3).

[0063] gDNA sequences:

[0064] sgRNA name sgRNA sequence (5'>3') PAM H11-S2 CTGAGCCAACAGTGGTAGTA(SEQ ID NO.3) AGG

[0065] Homologous recombination vector map Figure 2 As shown, the homologous recombination vector map is shown in the table below.

[0066]

[0067] The PCR primer names, sequences, product sizes, electrophoresis patterns and restriction site identification of the homologous recombination vector (name: GJS0220221213513-01) are as follows: Figure 3 and 4 shown.

[0068] Final vector identification conclusion: 2# cloning is correct and will be used for the next experiment

[0069] PCR identification:

[0070]

[0071] Enzyme digestion identification

[0072]

[0073] 1.2 Microinjection

[0074] The CRISPR / Cas9 system and homologous recombination vector samples were microinjected into fertilized eggs of mice with a C57BL / 6JGpt background; the injected fertilized eggs were transplanted into pseudo-pregnant female mice, and the mice born around 21 days were F0 generation mice. The genotypes were identified by PCR amplification, and the identification results were as follows: Figure 6 Combined with the identification strategy diagram, breeding recommendations: 5, 31.

[0075] 1.3 Identification of F0 generation mice

[0076] The F0 generation pups born to the recipient mice were numbered after their tails and toes were clipped at 5-7 days old, and their genomic DNA was extracted for PCR amplification and gene identification to confirm their genotype.

[0077]

[0078] Reaction system

[0079]

[0080]

[0081] Reaction Procedure

[0082]

[0083] 1.4 Breeding of positive F0 generation mice

[0084] After the positive F0 mice reached sexual maturity, they were mated with wild-type C57BL / 6JGpt mice to obtain F1 mice. The F1 mice were numbered after their tails and toes were cut at 5-7 days after birth, and their genotypes were identified by PCR. Figure 5 The identification method is the same as the F0 generation identification part, and the PCR identification results of the F1 generation mice are shown in Figure 7 As shown, all mice were positive according to the PCR identification results.

[0085] PCR identification primer sequences for F1 generation mice:

[0086]

[0087] 1.5 Positive F1 mice were bred with cre tool mice to construct CAG-LSL-mSirt1-3×Flag-WPRE-PolyA, POMC-Cre mice:

[0088] After the positive F1 mice reached sexual maturity, they were mated with POMC-Cre mice. The F1 CAG-LSL-mSirt1-3×Flag-WPRE-PolyA mice were mated with POMC-Cre mice to obtain offspring mice. The mice were numbered after their tails and toes were cut off at 5-7 days after birth, and their genomic DNA was extracted for PCR identification to confirm their genotypes. The results were as follows: Figure 8 shown.

[0089] Specific steps for identifying mouse genotypes:

[0090] The toes of the F2 mice were taken and genomic DNA was extracted using a kit, and the expression of the target gene was detected by PCR technology. The PCR reaction system was 2×Master Mix 10μL, genomic DNA 2μL, upstream and downstream primers 0.8μL, and up H2O 6.4μL.

[0091] The primers for PCR identification of F2 mice are as follows:

[0092]

[0093] PCR identification specific operation process

[0094] 1. Extraction of mouse DNA

[0095] 1.1 Cut 0.5-1 cm of the tail of a 2-week-old mouse, put it into a 1.5 mL autoclaved EP tube, and mark the tube.

[0096] 1.2 Preparation of rat tail digestion solution: 0.406g Tris, 0.11g (NH4)2SO4, 0.032g MgCl2, 2.5ml Triton X-100, 5ml beta-M, dilute to 500ml with high-pressure enzyme-free water.

[0097] 1.3. Centrifuge the mouse tail to the bottom of the tube, add 100 μl of digestion solution / tube. Heat in a metal bath at 95℃ for 15 min;

[0098] 1.4 After returning to room temperature, add 10 μl / tube of proteinase K and incubate in a 55°C water bath overnight;

[0099] 1.5 Termination of digestion: 95℃ metal bath for 10min;

[0100] 1.6 Dilution: add 400 μl / tube of UP water;

[0101] 2. PCR amplification of target gene

[0102] 2.1 Prepare the amplification system as described above, add to the PCR tube and mix thoroughly by centrifugation;

[0103] 2.2 PCR amplification was performed as described above;

[0104] 3. Identify PCR products by agarose gel electrophoresis;

[0105] 3.1 Preparation of glue tank:

[0106] Wash the glue board and comb with distilled water and dry them, and put the glue board into the glue tank;

[0107] Insert the comb vertically into the glue slot;

[0108] Place the glue tank horizontally on a horizontal platform.

[0109] 3.2 Gel preparation

[0110] Weigh 1.5 g of agarose powder using an electronic analytical balance and pour it into a conical flask containing 100 mL of 1xTAE electrophoresis buffer to prepare 1.5% agarose gel;

[0111] Place the flask in a microwave and heat the gel on medium heat until it boils. Take it out and shake it well, then heat it again to fully melt the agarose.

[0112] Add 10uL of nucleic acid dye to the melted agarose and shake gently;

[0113] 3.3 Glue laying

[0114] Pour 1.5% agarose gel into the gel tank, insert a comb, and let it stand at room temperature for about 20 minutes until the gel solidifies.

[0115] 3.4 Electrophoresis

[0116] After the gel solidifies, pull out the comb vertically and place the gel sheet into the electrophoresis tank;

[0117] Take 4uL DNA Maker and 8μl sample and add them into the gel wells in sequence;

[0118] The voltage was 120 V and the current was 400 mA for 40 min, and then the results were observed and photographed on a gel imaging system.

[0119] Interpretation of results: 146 / 147 is KI / KI-T, 148 is KI / Wt-W;

[0120] Wild type Wt / Wt: 1. No Target band was obtained in the PCR reaction; 2. A single WT band was obtained in the PCR reaction;

[0121] Heterozygous KI / Wt: 1PCR reaction can obtain the Target band; 2PCR reaction can obtain a single WT band;

[0122] Homozygous KI / KI: 1. Target band can be obtained in PCR reaction; 2. No single WT band is obtained in PCR reaction;

[0123] Cre positive T: 3PCR reaction can obtain Target band;

[0124] Cre negative W: No target band was obtained in 3PCR reaction.

[0125] Example 2

[0126] To study the differences in body weight, intake, and blood glucose between hypothalamic POMC neuron-specific SIRT1 overexpressing mice (hereafter referred to as OE mice) and their littermate control mice (hereafter referred to as WT) after diet-induced obesity.

[0127] In our study, we first used western blotting to detect the expression of SIRT1 gene in the hypothalamus tissue of the two types of mice. Next, we fed the two types of mice with a 45% high-fat diet for 7 weeks and recorded the phenotypes of the mice.

[0128] Western experimental steps:

[0129] Mouse hypothalamic tissue proteins were extracted using RIPA buffer (Cwbio) containing protease and phosphatase inhibitors (MCE) and quantified by BCA protein detection kit (Beyotime). The clarified supernatant was electrophoresed in a 10% SDS-PAGE gel and wet-transferred to a PVDF membrane. Then, 5% skim milk was used to block at room temperature for 1 hour, followed by incubation at 4°C overnight with rabbit anti-SIRT1 (CST#9475, 1:1000) and mouse anti-β-actin (Bioworld BS6007M, 1:1000) antibodies. The next day, the blot was incubated with a horseradish peroxidase-conjugated secondary antibody (proteintech) at room temperature for 1 hour. To capture protein bands, imaging was performed using an imaging system using an ECL chemiluminescence kit (Cwbio).

[0130] Phenotyping steps:

[0131] Body mass determination: Before and at the end of the experiment, the mice were placed in a holder (the skin of the holder had been peeled off) and then placed on an electronic balance. The reading was the body mass, accurate to 0.1 g.

[0132] Food intake measurement: In this experiment, all mice were allowed to eat freely, that is, given sufficient 45% high-fat diet pellets. The weight of the remaining food on the cage was recorded before and after the experiment. The unit of measurement of mass is gram (g).

[0133] Blood glucose and glucose tolerance test: The mice were fasted for 12 hours at 8:00 pm on the night before the end of the experiment, and then the tails were cut off to collect blood glucose. After fasting for 12 hours, fasting blood glucose was first measured; then 25% glucose solution (body weight*0.008 / mouse) was intraperitoneally injected, and the time of glucose administration was taken as the starting point (0min), and blood glucose was measured at 30min, 60min, 90min, and 120min respectively.

[0134] The test results are as follows Fig. 9 As shown, Fig. 9 As shown in a, the expression of SIRT1 in OE mice increased significantly, proving that the gene overexpression was successful. Fig. 9 As shown in b and 9c, after 7 weeks of feeding, OE mice were heavier than WT mice, but there was no statistically significant difference in the cumulative intake of the two types of mice. At the same time, OE mice showed impaired glucose tolerance (9d).

[0135] Sequence Listing:

[0136] SEQ ID NO.1: Recombinant sequence information: (the bold underline is the H11 site)

[0137]

[0138] SEQ ID NO.2: CAG-LSL-mSirt1-3×Flag-WPRE-PolyA Cas9-KI targeting genomic sequence: (KI fragment is bold underlined, 1340bp~3059bp is CAG promoter, 3060bp~3093bp is loxp, 3094bp~4687bp is stop, 4688bp~4721bp is loxp, 4742bp~4750bp is kozak, 4751bp~6961bp is mSirt1, 6962bp~7027bp is 3*Flag, 7028bp~7030bp is TAA, 7031bp~7618bp is WPRE, 7619bp~7850bp is PolyA.)

[0139]

[0140]

[0141]

Claims

1. A method for constructing a mouse model of SIRT1 overexpression in specific hypothalamic POMC neurons, characterized in that: The following steps are involved: Using CRISPR / Cas9 technology, the CAG-LSL-mSIRT1-3-3xFlag-WPRE-PolyA gene fragment was site-specifically inserted into the H11 site of the mouse; the sequence after the H11 site of the recombinant mouse is shown in SEQ ID NO.

1.

2. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 1, characterized in that: The CRISPR / Cas9 system and homologous recombination vector were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 mice; the F0 positive mice verified to be correct by PCR were mated with C57BL / 6JGpt mice to obtain a stably inherited F1 positive mouse model; the F1 mice were mated with POMC-Cre mice to obtain F2 mice and their genes were identified.

3. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 2, characterized in that: A homologous recombination vector carrying the target site homologous region and the target fragment was constructed; the transcribed sgRNA and Cas9 system and the purified homologous recombination vector sample were microinjected into the fertilized eggs of C57BL / 6JGpt mice to obtain F0 generation mice.

4. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 3, characterized in that: The identification primers of the homologous recombination vector are as follows: 1213513-SeqF1:tccccatcaagctgataaca; 1213513-SeqR2:GCTCAGGTGGAGGAATTGTT; 1213513-SeqF5:ccaagcaacaaacaacaatg; H11-3arm-TR: CTCAGGACCTCTGAAAGACC.

5. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 1, characterized in that: The sequence of sgRNA is 5′-CTGAGCCAACAGTGGTAGTA-3′.

6. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 2, characterized in that: The primers for identification of F0 generation mice are as follows: H11-tF2:ATGCCCACCAAAGTCATCAGTGTAG; H11-CAG-5tR2: AGGCGGGCCATTTACCGTAAGTTA; WPRE-tF1: TCAATCCAGCGGACCTTCCTT; H11-tR1: GACCCACTATTCTGCACCACTCATTAG; H11-wt-tF1a:AGTCTTTCCCTTGCCTCTGCT; H11-wt-tR1a: GGGTCTTCCACCTTTCTTCAG.

7. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 2, characterized in that: The primers for identification of F1 generation mice are as follows: H11-tF2:ATGCCCACCAAAGTCATCAGTGTAG; H11-CAG-5tR2: AGGCGGGCCATTTACCGTAAGTTA; WPRE-tF1: TCAATCCAGCGGACCTTCCTT; H11-tR2:TCACAGAAACCATATGGCGCTCC; H11-wt-tF1a:AGTCTTTCCCTTGCCTCTGCT; H11-wt-tR1a: GGGTCTTCCACCTTTCTTCAG.

8. The method for constructing a mouse model of specific hypothalamic POMC neuron SIRT1 overexpression according to claim 2, characterized in that: The primers for identification of F2 generation mice are as follows: WPRE-tF1: TCAATCCAGCGGACCTTCCTT; H11-tR3:ATATCCCCTTGTTCCCTTTCTGC; H11-wt-tF1a:AGTCTTTCCCTTGCCTCTGCT; H11-wt-tR1a: GGGTCTTCCACCTTTCTTCAG; oIMR1084: GCGGTCTGGCAGTAAAAACTATC; oIMR1085: GTGAACAGCATTGCTGTCACTT.

9. Use of the specific hypothalamic POMC neuron SIRT1 overexpression mouse model constructed by the method according to any one of claims 1 to 8 in the preparation of drugs.

10. The use according to claim 9, characterized in that: The medicine is a medicine for improving obesity.

Citation Information

Patent Citations

  • Mammalian cell lines with SIRT-1 gene knockout

    CA3141039A1

  • Construction method for conditional overexpression Yap1 gene mice model at H11 locus

    CN110093369A

  • Construction method and application of Alzheimer's disease mouse model

    CN116210645A

  • Application of SIRT1 activator in preparation of medicine for treating dilated cardiomyopathy

    CN116920096A